A
Aquestive Therapeutics Inc
NASDAQ:AQST
Aquestive Therapeutics Inc
NASDAQ:AQST
Price:
2.765 USD
0.55%
Updated:
Jun 10, 2024
Aquestive Therapeutics Inc
Other Long-Term Assets
|
Aquestive Therapeutics Inc
Other Long-Term Assets Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
Other Long-Term Assets
$1.4m
|
CAGR 3-Years
19%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Long-Term Assets
$19.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Long-Term Assets
$5.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Long-Term Assets
$16.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Long-Term Assets
$11.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Long-Term Assets
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
See Also
What is Aquestive Therapeutics Inc's Other Long-Term Assets?
Other Long-Term Assets
1.4m
USD
1.4m
USD
Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Other Long-Term Assets amounts to 1.4m USD.
What is Aquestive Therapeutics Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
43%
43%
Over the last year, the Other Long-Term Assets growth was -5%. The average annual Other Long-Term Assets growth rates for Aquestive Therapeutics Inc have been 19% over the past three years , 43% over the past five years .
You don't have any saved screeners yet
